MLchartDataset catalogue

LY317615

Term · Oncology and biomedicine · MLC-T-ONC-005003

A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent. Also called enzastaurin hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-005003
FieldOncology and biomedicine
Expansionsenzastaurin hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005003",
  "term": "LY317615",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent. Also called enzastaurin hydrochloride.",
  "expansions": [
    "enzastaurin hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ly317615/"
}

Record 10,435 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.